title: Are we doing the right phase III trials?
authors.forename: Adrian
authors.initials: A
authors.lastname: Burton
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic / Q000592:standards*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents